Bernasconi L et al., 2026-09-10: Italian investigation of 82 migrants with severe methemoglobinemia from dermal absorption of the gasoline additive N-methylaniline; methylene blue was used in 90%, with hemolytic anemia in 38 and two deaths.
Methylene blue therapy was used in 90% of the patients, often in repeated doses.
Bernasconi L et al., 2026-09-10: Italian investigation of 82 migrants with severe methemoglobinemia from dermal absorption of the gasoline additive N-methylaniline; methylene blue was used in 90%, with hemolytic anemia in 38 and two deaths. C3. Study type: coordinated clinical and toxicologic case series/outbreak investigation (Lampedusa and Pavia Poison Control Center, Italy), N=82, March 2024 – December 2025. Median MetHb 44.6% at presentation; 43% at 50% or greater. Methylene blue used in 90%, often repeated doses; delayed hemolytic anemia in 38 patients, frequently transfused; 2 deaths. Toxicologic analysis found N-methylaniline or metabolites in 37 of 39 tested patients and 1.1% N-methylaniline in a fuel sample. Dose not stated in the abstract text captured. Funder/conflicts: not stated in the PubMed record. Published in the New England Journal of Medicine 2026;395:983-991. Study type: uncontrolled series.
